Wolf Lisa G 4

What Happened

• Lisa G. Wolf, Chief Financial Officer of Tivic Health Systems, reported converting 92 restricted stock units (RSUs) into 92 shares of common stock on March 18, 2026 (transaction code M = exercise/conversion of derivative). The filing also reports a related disposition of 92 shares at a reported price of $0.00 (derivative disposition).
• The conversion shows no purchase price (acquired at N/A) and the disposition is recorded at $0 (total proceeds $0) in the filing excerpt provided.

Key Details

• Transaction date: March 18, 2026; Form 4 filed March 19, 2026 (timely).
• Transaction code: M (exercise or conversion of a derivative).
• Shares involved: 92 shares acquired via conversion; 92 shares reported disposed at $0.00.
• Shares owned after transaction: not disclosed in the provided excerpt.
• Relevant footnotes:
  • F1: Each RSU converts into one share of common stock.
  • F2: Reported numbers have been adjusted for a 1-for-17 reverse stock split on March 7, 2025.
  • F3: RSUs vesting schedule — 50% vested on Dec 18, 2024; remaining RSUs vest quarterly such that 100% vests by the third anniversary of the vesting commencement date.
• Filing status: appears timely (filed one day after the transaction date).

Context

• The filing reports a conversion of vested RSUs rather than an open-market buy or a cash sale. The simultaneous disposition at $0 is commonly seen when shares are withheld or transferred to satisfy tax withholding or other obligations, but the Form 4 excerpt does not specify the reason. This activity documents compensation-related equity conversion rather than a straightforward buy/sell indicating market sentiment.